Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: "Patrick Niaudet" Clear advanced filters

  • Although living donor kidney transplantation is often presented as the best option for patients awaiting renal transplantation, patients whose renal failure is the result of an inherited disease might not be suitable candidates for transplantation from a living related donor. In this Review, Patrick Niaudet discusses hereditary nephropathies for which living donor kidney transplantation is a viable option as well as diseases for which living donor transplantation is contraindicated.

    • Patrick Niaudet
    Reviews
    Nature Reviews Nephrology
    Volume: 6, P: 736-743

  • Ravani et al. report that rituximab is a safe and effective steroid-sparing and calcineurin-inhibitor-sparing agent in 46 children with idiopathic nephrotic syndrome over a median follow-up of 3 years. What is the risk-to-benefit profile of rituximab compared to that of the other available drugs for treating this disease?

    • Olivia Boyer
    • Patrick Niaudet
    News & Views
    Nature Reviews Nephrology
    Volume: 9, P: 562-563